Advanced Medical Solutions Group (LON:AMS) Earns Buy Rating from Peel Hunt

Advanced Medical Solutions Group (LON:AMS)‘s stock had its “buy” rating restated by stock analysts at Peel Hunt in a research note issued to investors on Wednesday, MarketBeat reports. They currently have a GBX 246 price target on the stock. Peel Hunt’s price target indicates a potential upside of 16.59% from the stock’s previous close.

AMS has been the subject of several other research reports. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a GBX 275 price objective on shares of Advanced Medical Solutions Group in a research note on Wednesday, July 16th. Berenberg Bank reiterated a “buy” rating and issued a GBX 300 price objective on shares of Advanced Medical Solutions Group in a research note on Wednesday. Three equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus price target of GBX 273.67.

Advanced Medical Solutions Group Stock Performance

Shares of Advanced Medical Solutions Group stock opened at GBX 211 on Wednesday. The business has a 50-day moving average of GBX 205.06 and a 200 day moving average of GBX 203.26. Advanced Medical Solutions Group has a 12 month low of GBX 168.40 and a 12 month high of GBX 255. The stock has a market capitalization of £456.04 million, a price-to-earnings ratio of 6,492.31, a price-to-earnings-growth ratio of 5.00 and a beta of 0.74. The company has a debt-to-equity ratio of 37.01, a current ratio of 8.39 and a quick ratio of 4.58.

Advanced Medical Solutions Group (LON:AMS) last announced its quarterly earnings data on Wednesday, September 17th. The company reported GBX 5.77 earnings per share (EPS) for the quarter. Advanced Medical Solutions Group had a return on equity of 4.57% and a net margin of 8.49%. As a group, sell-side analysts forecast that Advanced Medical Solutions Group will post 9.8159509 earnings per share for the current year.

Advanced Medical Solutions Group Company Profile

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®.